Motzer RJ - Search Results

1

Renal cell carcinoma: progress against an elusive tumor.

Motzer RJ. Motzer RJ. Semin Oncol. 2000 Apr;27(2):113-4. Semin Oncol. 2000. PMID: 10768590 No abstract available.

2

Ifosfamide-based chemotherapy for patients with resistant germ cell tumors: the Memorial Sloan-Kettering Cancer Center experience.

Motzer RJ, Bajorin DF, Vlamis V, Weisen S, Bosl GJ. Motzer RJ, et al. Semin Oncol. 1992 Dec;19(6 Suppl 12):8-11. Semin Oncol. 1992. PMID: 1336624

3

Current perspectives on the role of adjunctive surgery in combined modality treatment for patients with germ cell tumors.

Bajorin DF, Herr H, Motzer RJ, Bosl GJ. Bajorin DF, et al. Among authors: motzer rj. Semin Oncol. 1992 Apr;19(2):148-58. Semin Oncol. 1992. PMID: 1372757 Review.

4

"Poor-risk" germ cell tumors: current progress and future directions.

Motzer RJ, Bajorin DF, Bosl GJ. Motzer RJ, et al. Semin Oncol. 1992 Apr;19(2):206-14. Semin Oncol. 1992. PMID: 1372761 Review. No abstract available.

5

Phase II trial of suramin in patients with advanced renal cell carcinoma: treatment results, pharmacokinetics, and tumor growth factor expression.

Motzer RJ, Nanus DM, O'Moore P, Scher HI, Bajorin DF, Reuter V, Tong WP, Iversen J, Louison C, Albino AP, et al. Motzer RJ, et al. Cancer Res. 1992 Oct 15;52(20):5775-9. Cancer Res. 1992. PMID: 1394202 Clinical Trial.

6

A phase II trial of interleukin-2 and interferon alfa-2a in patients with advanced renal cell carcinoma.

Ilson DH, Motzer RJ, Kradin RL, Vogelzang NJ, Bajorin DF, Scher HI, Nanus D, O'Moore P, Marathias K, Bosl GJ. Ilson DH, et al. Among authors: motzer rj. J Clin Oncol. 1992 Jul;10(7):1124-30. doi: 10.1200/JCO.1992.10.7.1124. J Clin Oncol. 1992. PMID: 1607918 Clinical Trial.

7

Phase II trial of Didemnin B in patients with advanced renal cell carcinoma.

Motzer R, Scher H, Bajorin D, Sternberg C, Bosl GJ. Motzer R, et al. Invest New Drugs. 1990 Nov;8(4):391-2. doi: 10.1007/BF00198598. Invest New Drugs. 1990. PMID: 2084073 Clinical Trial.

8

Infrequent ras oncogene point mutations in renal cell carcinoma.

Nanus DM, Mentle IR, Motzer RJ, Bander NH, Albino AP. Nanus DM, et al. Among authors: motzer rj. J Urol. 1990 Jan;143(1):175-8. doi: 10.1016/s0022-5347(17)39905-6. J Urol. 1990. PMID: 2403598

9

Paclitaxel in germ cell cancer.

Motzer RJ, Chou TC, Schwartz L, Bosl GJ, Bajorin DF, Hutter H. Motzer RJ, et al. Semin Oncol. 1995 Jun;22(3 Suppl 6):12-5. Semin Oncol. 1995. PMID: 7597428 Review.

10

Interferon alfa-2a and 13-cis-retinoic acid in renal cell carcinoma: antitumor activity in a phase II trial and interactions in vitro.

Motzer RJ, Schwartz L, Law TM, Murphy BA, Hoffman AD, Albino AP, Vlamis V, Nanus DM. Motzer RJ, et al. J Clin Oncol. 1995 Aug;13(8):1950-7. doi: 10.1200/JCO.1995.13.8.1950. J Clin Oncol. 1995. PMID: 7636535 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

604 results

Search Page